AMRZ vs. SHW: Amrize vs. Sherwin-Williams Stock Comparison

Company Profile

Amrize (AMRZ) and Sherwin-Williams (SHW) both fall under the Materials industry group, but AMRZ is classified in Construction Materials while SHW is classified in Chemicals.

Sherwin-Williams (SHW) carries decades of public-market history since March 17, 1980, while Amrize (AMRZ) listed on June 23, 2025 — long-window comparisons have far more historical data on the SHW side.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Amrize (AMRZ) reports a negative beta of -0.05, suggesting inverse market sensitivity over the measurement window. That is uncommon for ordinary equities and can reflect commodity-linked or hedge-like exposure, but it can also come from statistical noise. Sherwin-Williams (SHW) has a non-negative beta of 1.02.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Sherwin-Williams (SHW) at 63.70% clears its industry range for ROE, a sharper capital-efficiency signal than Amrize (AMRZ) at 9.72%, which is closer to a typical peer reading.

Both Amrize (AMRZ) at 10.21% and Sherwin-Williams (SHW) at 10.74% keep about the typical share of revenue as profit for their industries — neither bottom line stands out from peers.

Both Amrize (AMRZ) at 21.16% and Sherwin-Williams (SHW) at 17.56% run core operations about as efficiently as their industries’ norm — neither stands out on operating profitability.

Profitability Metrics

Growth

Both Amrize (AMRZ) at 0.95% and Sherwin-Williams (SHW) at 2.06% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Both Amrize (AMRZ) at -7.16% and Sherwin-Williams (SHW) at -2.75% land near their industries' usual EPS growth ranges, so bottom-line momentum looks broadly in line with peers on both sides.

Growth Metrics

Financial Strength

Both Amrize (AMRZ) at 1.07 and Sherwin-Williams (SHW) at 0.71 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.

Amrize (AMRZ) at 0.55 is near its industry mid-range for debt-to-equity ratio, while Sherwin-Williams (SHW) at 3.72 sits above its benchmark range, pointing to a heavier debt load relative to equity.

Financial Strength Metrics

Dividends

Both Amrize (AMRZ) at 1.03% and Sherwin-Williams (SHW) at 0.91% pay solid, industry-typical yields, sitting squarely within their peers’ usual range.

Amrize (AMRZ) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Sherwin-Williams (SHW) reports a payout of 29.35%, ranking against industry peers normally.

Dividend Metrics

Valuation

Both Amrize (AMRZ) at 18.78 and Sherwin-Williams (SHW) at 31.66 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.

On P/S ratio, both Amrize (AMRZ) at 1.82 and Sherwin-Williams (SHW) at 3.34 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.

Amrize (AMRZ) at 1.76 sits near its industry’s typical P/B ratio, while Sherwin-Williams (SHW) at 20.78 prices above its benchmark range — SHW looks rich relative to book.

Valuation Metrics